Effect of formoterol on clinical parameters and lung functions in patients with bronchial asthma:: a randomised controlled trial

被引:34
作者
Akpinarli, A [1 ]
Tuncer, A [1 ]
Saraçlar, Y [1 ]
Sekerel, BE [1 ]
Kalayci, Ö [1 ]
机构
[1] Hacettepe Univ, Sch Med, Pediat Allergy & Asthma Div, Dept Pediat, TR-06100 Ankara, Turkey
关键词
bronchial asthma; formoterol; asthma; randomised controlled trial;
D O I
10.1136/adc.81.1.45
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aims-To determine the role of formoterol in the treatment of children with bronchial asthma who are symptomatic despite regular use of inhaled corticosteroids. Methods-A randomised, double blind, parallel group, placebo controlled study to investigate the effects of inhaled formoterol (12 mu g twice a day) in 32 children with moderate to severe bronchial asthma. The study consisted of two week run in periods and six week treatment periods, during both of which the patients continued their regular anti-inflammatory drugs. The efficacy parameters were symptom scores, bronchodilator use, daily peak expiratory flow rates (PEFR), methacholine hyper-reactivity, forced expiratory volume in one second (FEV,), lung volumes, and airway conductance. Results-Formoterol treatment for six weeks decreased symptom scores, PEFR variability, and the number of rescue salbutamol doses, and increased morning and evening PEFR significantly. No adverse reactions were seen. Conclusion-These findings suggest that inhaled formoterol is effective in controlling chronic asthma symptoms in children who are symptomatic despite regular use of inhaled corticosteroids.
引用
收藏
页码:45 / 48
页数:4
相关论文
共 19 条
[1]   FORMOTEROL - PHARMACOLOGY, MOLECULAR-BASIS OF AGONISM, AND MECHANISM OF LONG-DURATION OF A HIGHLY POTENT AND SELECTIVE BETA(2)-ADRENOCEPTOR AGONIST BRONCHODILATOR [J].
ANDERSON, GP .
LIFE SCIENCES, 1993, 52 (26) :2145-2160
[2]  
[Anonymous], 1987, AM REV RESPIR DIS, V136, P225
[3]  
ARVIDSSON P, 1991, EUR RESPIR J, V4, P1168
[4]  
Barnes PJ, 1996, CLIN EXP ALLERGY, V26, P738
[5]   FORMOTEROL, A NEW LONG-ACTING SELECTIVE BETA-2-AGONIST, DECREASES AIRWAY RESPONSIVENESS IN CHILDREN WITH ASTHMA [J].
BECKER, AB ;
SIMONS, FER .
LUNG, 1990, 168 :99-102
[6]   INHALED FORMOTEROL IN THE PREVENTION OF EXERCISE-INDUCED BRONCHOCONSTRICTION IN ASTHMATIC-CHILDREN [J].
BONER, AL ;
SPEZIA, E ;
PIOVESAN, P ;
CHIOCCA, E ;
MAIOCCHI, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (04) :935-939
[7]   PROBLEMS IN PLETHYSMOGRAPHIC ASSESSMENT OF CHANGES IN TOTAL LUNG CAPACITY IN ASTHMA [J].
BROWN, R ;
INGRAM, RH ;
MCFADDEN, ER .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1978, 118 (04) :685-692
[8]   BRONCHIAL REACTIVITY TO INHALED HISTAMINE - METHOD AND CLINICAL SURVEY [J].
COCKCROFT, DW ;
KILLIAN, DN ;
MELLON, JJA ;
HARGREAVE, FE .
CLINICAL ALLERGY, 1977, 7 (03) :235-243
[9]   GROWTH AND THE GROWTH-HORMONE AXIS IN PREPUBERTAL CHILDREN WITH ASTHMA [J].
CROWLEY, S ;
HINDMARSH, PC ;
MATTHEWS, DR ;
BROOK, CGD .
JOURNAL OF PEDIATRICS, 1995, 126 (02) :297-303
[10]  
*GLOB IN ASTHM, 1995, NATL HEART LUNG BLOO